Evidence map›Paper›PMID 25410864›Full record

ArticleJournal of virology2015

Nuclear import of adenovirus DNA involves direct interaction of hexon with an N-terminal domain of the nucleoporin Nup214.

Aurélia Cassany, Jessica Ragues, Tinglu Guan, Dominique Bégu, Harald Wodrich, Michael Kann, Glen R Nemerow, Larry Gerace

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Developing Antiviral Vaccines Based on AttenuatedPathogens (Basel, Switzerland) · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Viral interference of nucleocytoplasmic transport.The Journal of biological chemistry · 2025
    Review
  8. Article
  9. Mysteries of adenovirus packaging.Journal of virology · 2025
    Review
  10. Review
  11. Article
  12. Review
  13. Advances in the understanding of nuclear pore complexes in human diseases.Journal of cancer research and clinical oncology · 2024
    Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Aurélia CassanyDepartment of Cell and Molecular Biology, The Scripps Research Institute, La Jolla, California, USA University of Bordeaux, Microbiologie Fondamentale et Pathogénicité, UMR 5234, Bordeaux, France CNRS, Microbiologie Fondamentale et Pathogénicité, UMR 5234, Bordeaux, France aurelia.cassany@u-bordeaux.fr.
Jessica RaguesUniversity of Bordeaux, Microbiologie Fondamentale et Pathogénicité, UMR 5234, Bordeaux, France CNRS, Microbiologie Fondamentale et Pathogénicité, UMR 5234, Bordeaux, France.
Tinglu GuanDepartment of Cell and Molecular Biology, The Scripps Research Institute, La Jolla, California, USA.
Dominique BéguUniversity of Bordeaux, Microbiologie Fondamentale et Pathogénicité, UMR 5234, Bordeaux, France CNRS, Microbiologie Fondamentale et Pathogénicité, UMR 5234, Bordeaux, France.
Harald WodrichUniversity of Bordeaux, Microbiologie Fondamentale et Pathogénicité, UMR 5234, Bordeaux, France CNRS, Microbiologie Fondamentale et Pathogénicité, UMR 5234, Bordeaux, France.
Michael KannUniversity of Bordeaux, Microbiologie Fondamentale et Pathogénicité, UMR 5234, Bordeaux, France CNRS, Microbiologie Fondamentale et Pathogénicité, UMR 5234, Bordeaux, France Centre Hospitalier Universitaire de Bordeaux, Service de Virologie, Bordeaux, France.
Glen R NemerowDepartment of Immunology and Microbial Sciences, The Scripps Research Institute, La Jolla, California, USA.
Larry GeraceDepartment of Cell and Molecular Biology, The Scripps Research Institute, La Jolla, California, USA.
Centre National de la Recherche Scientifique · FRScripps Research Institute · US

Funding

AV INTEGRINS AND ADENOVIRUS INTERNALIZATIONR01HL054352 · NHLBI · SCRIPPS RESEARCH INSTITUTE, THE · PI NEMEROW, GLEN R · 1995 to 2016
$7.5M
Import of Adenovirus DNA into the nucleusR01AI055729 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI GERACE, LARRY R. · 2003 to 2007
$1.7M
NHLBI NIH HHS HL054352NHLBI NIH HHS R01 HL054352NIAID NIH HHS AI55729NIAID NIH HHS R01 AI055729
6 · The paper itself

Abstract

unlabelledIn this study, we characterized the molecular basis for binding of adenovirus (AdV) to the cytoplasmic face of the nuclear pore complex (NPC), a key step during delivery of the viral genome into the nucleus. We used RNA interference (RNAi) to deplete cells of either Nup214 or Nup358, the two major Phe-Gly (FG) repeat nucleoporins localized on the cytoplasmic side of the NPC, and evaluated the impact on hexon binding and AdV infection. The accumulation of purified hexon trimers or partially disassembled AdV at the nuclear envelope (NE) was observed in digitonin-permeabilized cells in the absence of cytosolic factors. Both in vitro hexon binding and in vivo nuclear import of the AdV genome were strongly reduced in Nup214-depleted cells but still occurred in Nup358-depleted cells, suggesting that Nup214 is a major binding site of AdV during infection. The expression of an NPC-targeted N-terminal domain of Nup214 in Nup214-depleted cells restored the binding of hexon at the NE and the nuclear import of protein VII (pVII), indicating that this region is sufficient to allow AdV binding. We further narrowed the binding site to a 137-amino-acid segment in the N-terminal domain of Nup214. Together, our results have identified a specific region within the N terminus of Nup214 that acts as a direct NPC binding site for AdV. IMPORTANCE: AdVs, which have the largest genome of nonenveloped DNA viruses, are being extensively explored for use in gene therapy, especially in alternative treatments for cancers that are refractory to traditional therapies. In this study, we characterized the molecular basis for binding of AdV to the cytoplasmic face of the NPC, a key step for delivery of the viral genome into the nucleus. Our data indicate that a 137-amino-acid region of the nucleoporin Nup214 is a binding site for the major AdV capsid protein, hexon, and that this interaction is required for viral DNA import. These findings provide additional insight on how AdV exploits the nuclear transport machinery for infection. The results could promote the development of new strategies for gene transfer and enhance understanding of the nuclear import of other viral DNA genomes, such as those of papillomavirus or hepatitis B virus that induce specific cancers.

Indexed as

Active Transport, Cell NucleusHost-Pathogen InteractionsVirus ReplicationAdenoviridaeAnimalsCapsid ProteinsCell LineDNA, ViralGene Knockdown TechniquesHumansNuclear Pore Complex ProteinsProtein BindingProtein Interaction MappingRNA InterferenceCapsid ProteinsDNA, Viralhexon capsid protein, AdenovirusNuclear Pore Complex ProteinsNUP214 protein, human

Identifiers

PMID25410864
PMCPMC4300731
OpenAlexW2063768479

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.